Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 3/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.44 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.39 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.34 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.34 |
| ▸ | MME | P08473 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12442311 | 0.98 | SLC1A3 (0.47) | SLC1A3SLC1A2CA2SLC1A1CA1 | |
| SCHEMBL1105036 | 0.98 | SLC1A3 (0.47) | SLC1A3SLC1A2CA2SLC1A1CA1 | |
| SCHEMBL14617630 | 0.87 | CA2 (0.48) | SLC1A3SLC1A2CA2SLC1A1CA1 | |
| SCHEMBL11960690 | 0.85 | CA2 (0.50) | SLC1A3SLC1A2CA2SLC1A1CA1 | |
| SCHEMBL27041452 | 0.82 | SLC1A2 (0.64) | SLC1A3SLC1A2CA2SLC1A1CA1 | |
| SCHEMBL117765 | 0.82 | SLC1A3 (0.58) | SLC1A3SLC1A2CA2SLC1A1ENPEP | |
| SCHEMBL12049834 | 0.81 | SLC1A3 (0.57) | SLC1A3SLC1A2CA2SLC1A1CA1 | |
| SCHEMBL12630685 | 0.80 | SLC1A3 (0.56) | SLC1A3SLC1A2CA2SLC1A1ENPEP | |
| SCHEMBL9750996 | 0.80 | SLC1A3 (0.56) | SLC1A3SLC1A2CA2SLC1A1ENPEP | |
| SCHEMBL15677327 | 0.80 | SLC1A3 (0.56) | SLC1A3SLC1A2CA2SLC1A1ENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130018110-A1 | HYDROGEL SYNTHESIS | THE UNIVERSITY OF READING (GB) | 2013-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130018110-A1 | HYDROGEL SYNTHESIS | HSF1, CDC37, PGF | SLC1A3 4086/4885SLC1A2 4165/4885CA2 1226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.